XML 28 R7.htm IDEA: XBRL DOCUMENT

Organization and Description of the Business	9 Months Ended
Organization and Description of the Business	Sep. 30, 2015
Organization and Description of the Business
Organization and Description of the Business	1. Organization and Description of the Business Trevena, Inc. (the “Company”) is a Delaware corporation that commenced operations in December 2007. The Company is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors. The Company operates in one segment and has its principal office in King of Prussia, Pennsylvania. Liquidity At September 30, 2015, the Company had an accumulated deficit of $167.0 million and its net loss was $35.1 million and $36.4 million for the nine months ended September 30, 2015 and 2014, respectively. The Company expects its cash and cash equivalents of $39.0 million and marketable securities of $129.9 million as of September 30, 2015, together with interest thereon, to be sufficient to fund its operating expenses and capital expenditure requirements into 2018.